Versant Ventures' latest biotech emerged on Thursday morning with a $62 million Series A from Bristol Myers Squibb, AbbVie ...

A Dutch biotech cre­at­ing nasal sprays to pro­tect against the flu and coro­n­avirus has raised an ad­di­tion­al $70 ...

Lon­za’s Synaf­fix has se­cured two sep­a­rate li­cens­ing deals with Boehringer In­gel­heim and Japan­ese drug­mak­er ...

Novo Holdings co-leads €32M Series A for Coave Therapeutics, which is developing gene therapies with its ALIGATER technology.

H1 acquires Ribbon Health to expand doctor-patient connections. Ribbon serves about 25M patients yearly; H1 aims to reach ...

French biotech MaaT Pharma says its acute graft-versus-host disease treatment exceeded expectations in a single-arm Phase 3 ...

Baby with genetic OTC deficiency shows promising response to iECURE's first-in-kind gene therapy, potentially avoiding liver ...

Revance Therapeutics said Wednesday it will have talks with Teoxane on its bid to take over Revance's company. But Crown ...

There's a shopping bonanza for new obesity medicines going on among a marquee cohort of biopharma investors who are ...

Transcarent acquires Accolade for $621M in cash deal led by CEO Glen Tullman, combining health navigation platforms.

Tenvie Therapeutics launches with $200M, acquires Denali drug candidates, led by Tony Estrada with NLRP3 and SARM1 inhibitors ...

Jasper Therapeutics continued building out the data for a drug designed to treat irritable skin conditions, though the latest ...